Attached files
| file | filename |
|---|---|
| EX-4.5 - EX-4.5 - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231ex45f4a99cc.htm |
| EX-32.2 - EX-32.2 - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231ex322f95cdc.htm |
| EX-32.1 - EX-32.1 - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231ex32141acfd.htm |
| EX-31.2 - EX-31.2 - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231ex3129e455d.htm |
| EX-31.1 - EX-31.1 - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231ex311ad6435.htm |
| EX-10.18 - EX-10.18 - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231ex101831313.htm |
| 10-K - 10-K - RHYTHM PHARMACEUTICALS, INC. | rytm-20191231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
|
(1) |
Registration Statement (Form S-3 No. 333-228323) of Rhythm Pharmaceuticals, Inc., |
|
(2) |
Registration Statement (Form S-8 No. 333-229642) pertaining to the 2017 Equity Incentive Plan and the 2017 Employee Stock Purchase Plan of Rhythm Pharmaceuticals, Inc., |
|
(3) |
Registration Statement (Form S-8 No. 333-223647) pertaining to the 2017 Equity Incentive Plan of Rhythm Pharmaceuticals, Inc., and |
|
(4) |
Registration Statement (Form S-8 No. 333-220925) pertaining to the 2017 Equity Incentive Plan and the 2017 Employee Stock Purchase Plan of Rhythm Pharmaceuticals, Inc.; |
of our report dated March 2, 2020, with respect to the consolidated financial statements of Rhythm Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Rhythm Pharmaceuticals, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Boston, Massachusetts
March 2, 2020